103 related articles for article (PubMed ID: 2134686)
1. Carcinogenic aromatic amine metabolism and DNA adduct detection in humans.
Kadlubar FF
Princess Takamatsu Symp; 1990; 21():329-38. PubMed ID: 2134686
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
3. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
5. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
[TBL] [Abstract][Full Text] [Related]
8. Assessment of exposure and susceptibility to aromatic amine carcinogens.
Kadlubar FF; Talaska G; Lang NP; Benson RW; Roberts DW
IARC Sci Publ; 1988; (89):166-74. PubMed ID: 3198199
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
10. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic acetylation of arylamines and DNA-adduct formation.
Weber WW; Levy GN; Martell KJ
Princess Takamatsu Symp; 1990; 21():119-26. PubMed ID: 2134671
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
[TBL] [Abstract][Full Text] [Related]
14. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
[TBL] [Abstract][Full Text] [Related]
15. Aromatic and heterocyclic amine metabolism and phenotyping in humans.
Lang NP; Kadlubar FF
Prog Clin Biol Res; 1991; 372():33-47. PubMed ID: 1956928
[TBL] [Abstract][Full Text] [Related]
16. [N-acetylation polymorphism versus differentiation of organic susceptibility to carcinogenic effect of homo- and heterocyclic aromatic amines].
Lutz W; Barański B; Krajewska B
Med Pr; 1994; 45(4):343-9. PubMed ID: 7968503
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer epidemiology and pathogenesis.
Ross RK; Jones PA; Yu MC
Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
[TBL] [Abstract][Full Text] [Related]
18. Molecular dosimetry of aromatic amines in human populations.
Skipper PL; Tannenbaum SR
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
Chou HC; Lang NP; Kadlubar FF
Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
[TBL] [Abstract][Full Text] [Related]
20. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
